Disclosures
Speaker for DePuy, A Johnson & Johnson Company, Stryker
Paid Consultant for Ortoma
Stock received from Astra Zeneca, Novo Nordisk, Ortoma
Support received from Biomet, DePuy, A Johnson & Johnson Company, JRI, Stryker, Zimmer
Editorial or Governing board of Orthopedics Today
All relevant financial disclosures have been mitigated.
Disclosures complete: Aug 31, 2024
*Please note that Global Link resources are not part of the CME offered for the 2025 ISAKOS Congress.